310 related articles for article (PubMed ID: 8624687)
1. Sensory pathophysiology in chronic acquired demyelinating neuropathy.
Krarup C; Trojaborg W
Brain; 1996 Feb; 119 ( Pt 1)():257-70. PubMed ID: 8624687
[TBL] [Abstract][Full Text] [Related]
2. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and neurophysiological features of 700 patients with diabetic peripheral neuropathy].
Liu MS; Hu BL; Cui LY; Tang XF; Du H; Li BH
Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):173-6. PubMed ID: 15840253
[TBL] [Abstract][Full Text] [Related]
4. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
[TBL] [Abstract][Full Text] [Related]
5. What is the best diagnostic index of conduction block and temporal dispersion?
Oh SJ; Kim DE; Kuruoglu HR
Muscle Nerve; 1994 May; 17(5):489-93. PubMed ID: 8159178
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy.
Clouston PD; Kiers L; Zuniga G; Cros D
Electroencephalogr Clin Neurophysiol; 1994 Aug; 93(4):245-54. PubMed ID: 7521284
[TBL] [Abstract][Full Text] [Related]
7. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.
Yiannikas C; Vucic S
Muscle Nerve; 2008 Nov; 38(5):1447-1454. PubMed ID: 18932207
[TBL] [Abstract][Full Text] [Related]
8. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2008 Aug; 38(2):1036-45. PubMed ID: 18642356
[TBL] [Abstract][Full Text] [Related]
9. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
[TBL] [Abstract][Full Text] [Related]
10. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
[TBL] [Abstract][Full Text] [Related]
11. [Study on the latency difference between compound muscle and sensory nerve action potentials].
Hasegawa O; Gondo G; Wada N; Matsumoto S; Mimura E
No To Shinkei; 2001 Jun; 53(6):541-5. PubMed ID: 11436338
[TBL] [Abstract][Full Text] [Related]
12. Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration.
Vucic S; Black K; Chong PS; Cros D
Clin Neurophysiol; 2007 Jan; 118(1):124-30. PubMed ID: 17095292
[TBL] [Abstract][Full Text] [Related]
13. Proximal motor conduction evaluated by transcranial magnetic stimulation in acquired inflammatory demyelinating neuropathies.
Inaba A; Yokota T; Saito Y; Ichikawa T; Mizusawa H
Clin Neurophysiol; 2001 Oct; 112(10):1936-45. PubMed ID: 11595155
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological patterns of diabetic polyneuropathy.
Bagai K; Wilson JR; Khanna M; Song Y; Wang L; Fisher MA
Electromyogr Clin Neurophysiol; 2008; 48(3-4):139-45. PubMed ID: 18551834
[TBL] [Abstract][Full Text] [Related]
15. Abnormal sensory nerve conduction in multifocal demyelinating neuropathy with persistent conduction block.
Valls-Solé J; Cruz Martinez A; Graus F; Saiz A; Arpa J; Grau JM
Neurology; 1995 Nov; 45(11):2024-8. PubMed ID: 7501153
[TBL] [Abstract][Full Text] [Related]
16. Compound sensory action potential in normal and pathological human nerves.
Krarup C
Muscle Nerve; 2004 Apr; 29(4):465-83. PubMed ID: 15052613
[TBL] [Abstract][Full Text] [Related]
17. Normal sensory conduction in the nerves of the leg in man.
Behse F; Buchthal F
J Neurol Neurosurg Psychiatry; 1971 Aug; 34(4):404-14. PubMed ID: 5096554
[TBL] [Abstract][Full Text] [Related]
18. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between axonal and demyelinating neuropathies: identical segments recorded from proximal and distal muscles.
Raynor EM; Ross MH; Shefner JM; Preston DC
Muscle Nerve; 1995 Apr; 18(4):402-8. PubMed ID: 7715625
[TBL] [Abstract][Full Text] [Related]
20. [Interrelationship among nerve conduction velocity, amplitudes of compound muscle and compound nerve action potentials in diabetic neuropathy].
Hasegawa O; Matsumoto S; Iino M; Mori I; Arita T; Baba Y
No To Shinkei; 1999 Oct; 51(10):863-6. PubMed ID: 10553586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
